Circulating Tumor Cell

A microchip-based device has been developed that can isolate, enumerate and analyze circulating tumor cells (CTCs) from a blood sample. CTCs are viable cells from solid tumors carried in the bloodstream at a level of one in a billion cell. Because of their rarity and fragility, it has not been possible to get information from CTCs that could help clinical decision-making, but the new device – called the “CTC-chip,”– has the potential to be an invaluable tool for monitoring and guiding cancer treatment. Read More >

Experience Matters

The Massachusetts General Hospital Cancer Center is recognized as a leader in cancer surgery, with its surgeons treating some of the most challenging and complex cases, referred from throughout New England and the US. Examples are:

• The Cancer Center surgeons perform more liver surgery than any other hospital in Massachusetts
• They perform the most pancreatic surgery in the Northeast
  Watch Video
  

• The Cancer Center's thoracic surgeons are among those performing the greatest number of esophagectomies in the Massachusetts
  

  Many studies have shown that high-volume esophageal cancer centers (those performing more than six esophagectomies per year) have better results. Massachusetts General Hospital Cancer Center is a
  high-volume center, performing over 60 esophagectomies a year.
  Watch Video

The Cancer Center offers dedicated surgeons who have been pioneers in the development of new treatment approaches for both rare and common cancers.
Learn More About Surgery
More Specialty Surgery

• Gynecologic Oncology
• Neurosurgery
• Oncologic Urology
• Oral Maxillofacial Surgery
• Orthopedic Oncology
• Pediatric Surgery

All other Departments and Services in the Massachusetts General Hospital